Clinical Trial Update: Examination of Efficacy and Safety of Baricitinib in RA Patients [Phase 2]

View source ↗

Summary

Phase 2 trial examining efficacy and safety of baricitinib in rheumatoid arthritis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Baricitinib (baricitinib)

Snippet

Sponsor: Shinshu University | Conditions: Rheumatoid Arthritis | Phase 2 | Status: UNKNOWN